Orchid Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Orchid Pharma has a total shareholder equity of ₹11.7B and total debt of ₹1.3B, which brings its debt-to-equity ratio to 11.5%. Its total assets and total liabilities are ₹15.5B and ₹3.8B respectively. Orchid Pharma's EBIT is ₹774.4M making its interest coverage ratio 4.7. It has cash and short-term investments of ₹2.7B.
Key information
11.5%
Debt to equity ratio
₹1.34b
Debt
| Interest coverage ratio | 4.7x |
| Cash | ₹2.67b |
| Equity | ₹11.69b |
| Total liabilities | ₹3.84b |
| Total assets | ₹15.54b |
Recent financial health updates
Recent updates
We Ran A Stock Scan For Earnings Growth And Orchid Pharma (NSE:ORCHPHARMA) Passed With Ease
Jun 12
Orchid Pharma Limited's (NSE:ORCHPHARMA) Intrinsic Value Is Potentially 17% Below Its Share Price
May 08Orchid Pharma Limited's (NSE:ORCHPHARMA) P/S Is Still On The Mark Following 72% Share Price Bounce
Feb 28Does Orchid Pharma (NSE:ORCHPHARMA) Have A Healthy Balance Sheet?
Feb 06Orchid Pharma Limited (NSE:ORCHPHARMA) Looks Just Right With A 33% Price Jump
Dec 18Financial Position Analysis
Short Term Liabilities: ORCHPHARMA's short term assets (₹7.9B) exceed its short term liabilities (₹2.6B).
Long Term Liabilities: ORCHPHARMA's short term assets (₹7.9B) exceed its long term liabilities (₹1.2B).
Debt to Equity History and Analysis
Debt Level: ORCHPHARMA has more cash than its total debt.
Reducing Debt: ORCHPHARMA had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: ORCHPHARMA's debt is well covered by operating cash flow (93.7%).
Interest Coverage: ORCHPHARMA's interest payments on its debt are well covered by EBIT (4.7x coverage).